Goslee Signals

M&A signal intelligence from SEC EDGAR filings

Total filings: 34312
Classified: 34312
High-signal (≥0.75): 2959
Tickers tracked: 6105
Alerts sent: 0

What you're looking at

Real-time M&A signal intelligence from SEC EDGAR. Every 15 minutes we pull every new activist 13D, material 8-K, tender offer, and merger proxy filed with the SEC. Claude AI reads each filing and scores it 0–1 on the likelihood it indicates an impending acquisition or strategic transaction.

The Top Tickers panel on the left ranks companies by a composite score that weights signal strength, confidence, form type, and recency over the last 90 days. The Recent Classified Filings panel on the right is the live feed of every classified filing — click any row to see Claude's full reasoning. Filings scoring ≥ 0.75 are flagged as high-signal candidates and (when configured) push a Telegram alert.

Hover any column header for definitions.  ·  Composite score = EDGAR weight only in v1; news, language, and insider layers reserved for future tiers.

Top Tickers (90d)

Ranked by composite M&A signal

Ticker Score Filings Last
SKYT
SkyWater Technology, Inc
 1.00 1 2026-07-31
AVNS
AVANOS MEDICAL, INC.
 1.00 1 2026-07-30
LBRDA
Liberty Broadband Corp
 1.00 1 2026-08-20
ACV
ACV Auctions Inc.
 1.00 2 2026-10-16
IA
INNOVATIVE SOLUTIONS & SUPPORT
 1.00 1 2026-10-06
SELECTIS
SELECTIS HEALTH, INC.
 1.00 1 2026-10-09
SLP
Simulations Plus, Inc.
 0.99 3 2026-10-06
HLMN
Hillman Solutions Corp.
 0.99 2 2026-09-03
WBS
WEBSTER FINANCIAL CORP
 0.99 2 2026-08-20
FELE
FRANKLIN ELECTRIC CO INC
 0.99 1 2026-09-08
NSTS
NSTS Bancorp, Inc.
 0.99 3 2026-10-01
BLFS
BIOLIFE SOLUTIONS INC
 0.99 4 2026-10-06
EA
ELECTRONIC ARTS INC.
 0.99 2 2026-08-04
TALK
Talkspace, Inc.
 0.99 2 2026-08-17
GRTX
Galera Therapeutics, Inc.
 0.99 2 2026-08-03
MDV
MODIV INDUSTRIAL, INC.
 0.99 2 2026-08-12
LPRO
Open Lending Corp
 0.98 2 2026-07-31
LPSN
LIVEPERSON INC
 0.98 3 2026-09-04
ALOT
AstroNova, Inc.
 0.98 4 2026-08-26
LUXF
LUXFER HOLDINGS PLC
 0.98 1 2026-09-17
LGMK
LogicMark, Inc.
 0.98 1 2026-10-13
ELSE
ELECTRO SENSORS INC
 0.98 1 2026-07-31
VRNS
VARONIS SYSTEMS INC
 0.98 1 2026-10-15
BMBL
Bumble Inc.
 0.98 1 2026-10-13
ACA
Arcosa, Inc.
 0.98 4 2026-10-23
ESQ
Esquire Financial Holdings, In
 0.98 3 2026-10-15
ATAI
AtaiBeckley Inc.
 0.98 5 2026-09-11
HZO
MARINEMAX INC
 0.98 3 2026-10-02
FBRX
Forte Biosciences, Inc.
 0.98 7 2026-08-27
ACVA
ACV Auctions Inc.
 0.98 13 2026-10-19

Recent Classified Filings

Most recent 50

Filed Form Ticker Signal Score Summary
2026-10-26 17:30 8-K PPTA other 0.05 Warrant amendment and U.S. Army tungsten exploration funding agreement; no M&A indicators.
2026-10-26 17:29 SC TO-I — other 0.00 Issuer self-tender offer to repurchase own units; no M&A signal.
2026-10-26 17:27 8-K — other 0.05 Routine 8-K reporting unregistered equity sales, distributions, and portfolio updates for a private income fun
2026-10-26 17:27 8-K BEAG material agreement 0.72 SPAC extension to June 2027 with sponsor commitment and redemption reversals signal active M&A pursuit.
2026-10-26 17:26 SC TO-I — other 0.05 Issuer self-tender offer to repurchase units; routine capital management, not M&A.
2026-10-26 17:26 8-K DG other 0.02 FTC lawsuit filed against Dollar General for alleged consumer protection violations; no M&A relevance.
2026-10-26 17:25 8-K FFR other 0.15 8-K discloses completed acquisition of robotics business; past transaction, not impending.
2026-10-26 17:25 8-K IQST material agreement 0.72 iQSTEL securing $3M financing to fund planned acquisition of 51% controlling stake in Ultranet Telecom Group b
2026-10-26 17:25 8-K FFAI other 0.15 Disposition of robotics business to FFR; divestiture activity unrelated to FFAI acquisition risk.
2026-10-26 17:24 SC TO-I BOTI other 0.15 Issuer self-tender offer completed; share repurchase program unrelated to M&A activity.
2026-10-26 17:23 SC TO-I OCIC other 0.05 Issuer self-tender offer to repurchase up to 5% of shares; routine capital management, not M&A.
2026-10-26 17:23 8-K CBK other 0.05 Routine quarterly earnings release and dividend declaration; no M&A signals detected.
2026-10-26 17:23 8-K EVEX other 0.05 NYSE delisting notice for warrants due to abnormally low price; not M&A-related.
2026-10-26 17:23 8-K — other 0.05 Routine 8-K disclosing unregistered equity sales and portfolio/distribution updates; no M&A indicators.
2026-10-26 17:22 8-K GJO other 0.00 Routine distribution notice from STRATS trust; no M&A activity indicated.
2026-10-26 17:22 8-K PANAMERA other 0.05 Financial restatement due to undisclosed employment litigation; no M&A signal present.
2026-10-26 17:21 8-K — other 0.00 Routine distribution notice from a structured finance trust; no M&A signals.
2026-10-26 17:21 8-K GJP other 0.00 Routine distribution statement from STRATS trust; no M&A activity indicated.
2026-10-26 17:20 SC TO-I KFS other 0.05 Issuer tender offer for own shares at NAV; routine share repurchase program, not M&A-related.
2026-10-26 17:20 8-K STRATS other 0.05 Routine distribution statement for structured finance trust; no M&A indicators.
2026-10-26 17:20 PREM14A SKYE merger agreement 0.98 Skye Bioscience acquiring Redx Pharma via scheme of arrangement; definitive transaction agreement with stockho
2026-10-26 17:17 8-K LXFR merger agreement 0.98 Definitive merger agreement with Wynnchurch Capital to acquire Luxfer via scheme of arrangement; shareholder v
2026-10-26 17:15 8-K VENU material agreement 0.05 Material development and financing agreements for amphitheater project; no M&A signal.
2026-10-26 17:14 8-K WST other 0.25 West Pharmaceutical refinanced credit facility; boilerplate M&A language suggests financing flexibility but no
2026-10-26 17:14 8-K GRBK officer change 0.15 Co-CEO appointed to board; routine corporate governance change with no M&A indicators.
2026-10-26 17:10 8-K CYCU officer change 0.15 Director independence violation and board seat appointment; routine governance matter with no M&A indicators.
2026-10-26 17:09 8-K EQ other 0.05 Private placement financing and milestone achievement in EQ504 trial; no M&A signals.
2026-10-26 17:06 8-K — other 0.05 Routine capital structure amendment authorizing new share classes for private offering; no M&A indicators.
2026-10-26 17:04 8-K ONCO other 0.15 Reverse stock split announcement (1:10 ratio); no M&A signals present.
2026-10-26 17:04 8-K — other 0.05 Routine 8-K reporting unregistered equity sales, NAV pricing, and share repurchase plan. No M&A signals.
2026-10-26 17:03 8-K NE other 0.05 Routine quarterly earnings announcement with teleconference and slide presentation; no M&A signals.
2026-10-26 17:03 8-K BRO other 0.00 Routine earnings announcement; no M&A signal present.
2026-10-26 17:01 8-K NMFC other 0.05 Stock repurchase program extension announcement; no M&A indicators present.
2026-10-26 17:00 8-K MEDS material agreement 0.85 DataMeds AI entering non-binding LOI for multi-asset acquisition including IP, licenses, and controlling stake
2026-10-26 17:00 8-K GOAI other 0.08 Debt covenant dispute with lender over restricted issuance; no M&A signal detected.
2026-10-26 17:00 8-K XBP officer change 0.15 Chairman chooses not to stand for re-election; routine governance matter with no M&A indicators.
2026-10-26 17:00 8-K YHNA other 0.15 SPAC delisting notice due to failed minimum market value requirements; no M&A activity indicated.
2026-10-26 17:00 8-K BRBS other 0.05 Routine quarterly earnings announcement with no M&A-related content or language.
2026-10-26 17:00 8-K FLD other 0.15 Reverse stock split approval; routine corporate governance matter unrelated to M&A activity.
2026-10-26 16:57 8-K ZEO other 0.05 Nasdaq delisting notice extension; no M&A signal present.
2026-10-26 16:55 8-K LYCA other 0.00 Routine IPO-related corporate governance filing; no M&A signals present.
2026-10-26 16:54 8-K NUE other 0.05 Routine earnings report filing with no M&A signals or transaction indicators.
2026-10-26 16:53 8-K RLYB merger agreement 0.98 Rallybio acquiring Avenzo via definitive merger agreement signed May 31, 2026; closing expected November 6, 20
2026-10-26 16:52 8-K AABC other 0.05 Routine 8-K disclosing unregistered equity sales, NAV calculations, repurchases, and distributions. No M&A sig
2026-10-26 16:49 8-K GENVOR other 0.05 IP assignment agreement with founder; no M&A signal. Routine corporate governance matter.
2026-10-26 16:49 8-K SXI officer change 0.15 Board director retirement and succession planning with new director appointment; routine corporate governance
2026-10-26 16:48 8-K SORN officer change 0.15 Routine board and CFO transitions at SPAC with no M&A language or strategic review indicators.
2026-10-26 16:47 8-K MIRM other 0.05 Clinical trial results announcement for ATEBRIOZ; no M&A indicators present.
2026-10-26 16:46 8-K KNTK other 0.05 Settlement of NGL purchase agreement dispute with Energy Transfer; no M&A signal.
2026-10-26 16:44 8-K LGVN other 0.05 Clinical trial results update; no M&A, activist, or strategic transaction signals present.
Goslee Signals · EDGAR-powered M&A intelligence